Corteva, Inc. (BMV:CTVA)
| Market Cap | 100.33B |
| Revenue (ttm) | 141.62B |
| Net Income | 6.33B |
| EPS | 10.08 |
| Shares Out | n/a |
| PE Ratio | 15.88 |
| Forward PE | 10.84 |
| Dividend | 10.26 (6.41%) |
| Ex-Dividend Date | Dec 1, 2026 |
| Volume | 8,507 |
| Open | 161.00 |
| Previous Close | 180.00 |
| Day's Range | 159.30 - 161.00 |
| 52-Week Range | 159.30 - 1,500.41 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2026 |
About Corteva
Corteva, Inc. operates as a pure-play agriculture company in the United States, Canada, the Middle East, Africa, Europe, Latin America, and Asia. The company provides products that protect against weeds, insects, diseases, nematodes, and other pests, as well as supports crop health via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers tools to improve productivity and help keep fields free of weeds, insects, and diseases. The company offers herbicides, soybeans, cereals, fruit... [Read more]
News
Corteva reinstated with an Equal Weight at Barclays
Barclays reinstated coverage of Corteva (CTVA) with an Equal Weight rating and $11 price target The firm cites the company’s weaker than expected Q3 results and “surprise” guidance cut for…
CTVA Investors Have Opportunity to Join Corteva, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $CTVA--CTVA Investors Have Opportunity to Join Corteva, Inc. Fraud Investigation with SBS Law.
Did You Lose Money on Corteva, Inc. Stock? The Law Offices of Howard G.
BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Corteva, Inc. ("Corteva" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today repo...
Corteva price target lowered to $13 from $16 at Mizuho
Mizuho lowered the firm’s price target on Corteva (CTVA) to $13 from $16 and keeps an Outperform rating on the shares. The new Corteva is now a pure-play crop protection…
Corteva price target lowered to $14 from $17 at KeyBanc
KeyBanc lowered the firm’s price target on Corteva (CTVA) to $14 from $17 and keeps an Overweight rating on the shares. The firm believes the company is facing an earning…
Lost Money on Corteva, Inc. Shares? The Law Offices of Frank R.
LOS ANGELES--(BUSINESS WIRE)--Corteva, Inc. ("Corteva" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is invest...
Corteva price target lowered to $14 from $15 at BMO Capital
BMO Capital lowered the firm’s price target on Corteva (CTVA) to $14 from $15 and keeps an Outperform rating on the shares. The firm notes that the abrupt Brazil-driven guidance…
Corteva price target lowered to $11 from $17 at RBC Capital
RBC Capital lowered the firm’s price target on Corteva (CTVA) to $11 from $17 and keeps an Outperform rating on the shares after its worse-than-expected Q3 results. The company missed…
Corteva price target lowered to $13 from $18 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews lowered the firm’s price target on Corteva (CTVA) to $13 from $18 and keeps an Overweight rating on the shares.
Corteva price target lowered to $10 from $15 at UBS
UBS lowered the firm’s price target on Corteva (CTVA) to $10 from $15 and keeps a Neutral rating on the shares.
Corteva price target lowered to $16 from $19 at JPMorgan
JPMorgan lowered the firm’s price target on Corteva (CTVA) to $16 from $19 and keeps an Overweight rating on the shares. The firm cites its lowered EBITDA estimates for the…
Corteva price target lowered to $10.30 from $13.65 at Citi
Citi lowered the firm’s price target on Corteva (CTVA) to $10.30 from $13.65 and keeps a Neutral rating on the shares.
Corteva Earnings Call Transcript: Q3 2026
New-product growth and productivity supported results outside Latin America, but Brazil’s inventory overhang and market weakness drove a sharp 2026 EBITDA guidance cut. Management expects 2027 growth and is reviewing costs and Brazil’s operating model.
Corteva Earnings release: Q3 2026
Corteva released its Q3 2026 earnings on November 12, 2026, summarizing the period's financial results.
Corteva Slides: Q3 2026
Corteva has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 12, 2026.
Corteva Quarterly report: Q3 2026
Corteva has published its Q3 2026 quarterly earnings report on November 12, 2026.
Corteva reports Q3 adjusted EPS 6c, consensus 10c
Reports Q3 revenue $1.59B, consensus $1.77B. Luke Kissam CEO: “We executed well against the things we can control. New products performed strongly, productivity delivered, and we generated broad-based...
Corteva sees FY26 adjusted pro forma operating EPS 76c-80, consensus $1.07
“Agricultural fundamentals continue to be supported by the need for growers to improve productivity and protect yield, driving demand for differentiated technologies. However, Crop Protection market c...
Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook
Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds Pricing pressure was concentrated in North America and Lat...
Corteva Declares Quarterly Dividend
INDIANAPOLIS, Oct. 23, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors, at its quarterly meeting, has authorized a common stock dividend of $0.05 cents per share...
Corteva Announces Dates for Third Quarter 2026 Earnings Release and Webcast
INDIANAPOLIS, Oct. 6, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its third quarter 2026 earnings on Wednesday, November 11, 2026, after the stock market close via ...
Vylor Added to the S&P 500; Twilio Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600: Vylor Inc. (NYSE: VYLR) was added to the S&P 500 on Octo...
US states filed fraud lawsuit over Corteva's Vylor spinoff
A group of US states sued Corteva and Vylor on Thursday, alleging Corteva's spinoff of its seed business to Vylor was a fraudulent attempt to avoid tens of billions in legacy liabilities related to ...

